FeaturedNeurologyNeuroscience·April 11, 2026·7 min readParkinson’s Meds Accidentally Trigger Bacteria to “Eat” LevodopaHow does gut bacteria affect Parkinson’s medication? COMT inhibitors trigger the growth of E. faecalis, which metabolizes levodopa before it can reach the brain.Read More
FeaturedNeurologyNeuroscience·April 9, 2026·7 min readMicronutrients Could Stop Brain Bleeding in Alzheimer’s TreatmentResearchers have found that combining Alzheimer’s medications with molecules derived from grapes and turmeric is more effective and safer than current treatments, potentially reducing risks of brain swelling.Read More
FeaturedGeneticsNeuroscience·April 8, 2026·8 min readOzempic Weight Loss Success Varies by DNAA new study of 28,000 people identifies genetic markers in the GLP1R and GIPR genes that explain why some patients lose more weight or experience more nausea on GLP-1 drugs.Read More
AutismFeaturedGeneticsNeuroscience·April 8, 2026·9 min readOne Compound Repairs Neurons with Autism MutationsResearchers used a library of 520 FDA-approved drugs and zebrafish "behavioral fingerprints" to identify precision medicine candidates for autism. Levocarnitine emerged as a top drug for reversing symptoms linked to specific risk genes.Read More
FeaturedNeurologyNeurosciencePain·April 1, 2026·9 min readHigh-Potency Opioid Relieves Pain Without the RisksResearchers have engineered a novel nitazene-based opioid, DFNZ, that provides potent pain relief without causing respiratory depression or addiction. The "superagonist" drug could revolutionize treatment for chronic pain and opioid use disorder.Read More
FeaturedNeurologyNeuroscience·March 16, 2026·7 min readTurning Plastic Bottles into Parkinson’s MedicationResearchers have successfully turned discarded plastic bottles into L-DOPA, proving that plastic waste is a valuable resource for human health.Read More
FeaturedNeuroscience·March 14, 2026·9 min readMost Insomnia Meds Don’t Worsen Sleep ApneaNew research identifies which insomnia medications protect the breath while promoting rest, debunking long-held fears about "sleep-inducing" drugs.Read More
FeaturedNeuroscience·March 10, 2026·13 min readWhy GLP-1 Drugs Affect Men and Women DifferentlyA new atlas reveals that GLP-1—the backbone of blockbuster weight-loss drugs—is mapped differently in the male and female brain.Read More
FeaturedNeurologyNeuroscience·March 6, 2026·9 min read70-Year-Old Drug Could Stop Epilepsy SeizuresScientists discover that stabilizing a single ion transporter can flip the switch from seizure activity to healthy brain inhibition.Read More
FeaturedNeurologyNeuroscience·March 2, 2026·7 min readBeyond Weight Loss: Ozempic Linked to Migraine ReductionUnexpected relief. New research shows that patients taking GLP-1 drugs for diabetes or weight loss also experience fewer emergency room visits and need fewer medications for their chronic migraines.Read More
FeaturedNeurologyNeuroscience·March 2, 2026·9 min readLow-Dose Lithium May Shield Against Verbal Memory LossA new pilot study reveals that low-dose lithium may act as a neuroprotective shield, slowing verbal memory loss in patients at risk for Alzheimer’s.Read More
FeaturedNeuroscience·February 21, 2026·7 min readMounjaro’s Active Ingredient Slashes Alcohol IntakeFrom weight loss to sobriety. New research reveals how the active ingredient in Mounjaro "mutes" the brain's reward system to slash alcohol cravings.Read More
